JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on March 6, 2003; DOI: 10.1124/jpet.102.046185


0022-3565/03/3053-1163-1172$20.00
JPET 305:1163-1172, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.102.046185v1
305/3/1163    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lash, L. H.
Right arrow Articles by Elfarra, A. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lash, L. H.
Right arrow Articles by Elfarra, A. A.

TOXICOLOGY

Roles of Necrosis, Apoptosis, and Mitochondrial Dysfunction in S-(1,2-Dichlorovinyl)-L-cysteine Sulfoxide-Induced Cytotoxicity in Primary Cultures of Human Renal Proximal Tubular Cells

Lawrence H. Lash, David A. Putt, Sarah E. Hueni, Renee J. Krause, and Adnan A. Elfarra

Department of Pharmacology, Wayne State University School of Medicine, Detroit, Michigan (L.H.L., D.A.P., S.E.H.) and Department of Comparative Biosciences, University of Wisconsin School of Veterinary Medicine, Madison, Wisconsin (R.J.K., A.A.E.)

S-(1,2-Dichlorovinyl)-L-cysteine (DCVC) is the penultimate nephrotoxic metabolite of the environmental contaminant trichloroethylene. Although metabolism of DCVC by the cysteine conjugate {beta}-lyase is the most studied bioactivation pathway, DCVC may also be metabolized by the flavin-containing monooxygenase (FMO) to yield DCVC sulfoxide (DCVCS). Renal cellular injury induced by DCVCS was investigated in primary cultures of human proximal tubular (hPT) cells by assessment of time- and concentration-dependent effects on cellular morphology, acute cellular necrosis, apoptosis, mitochondrial function, and cellular glutathione (GSH) status. Confluent hPT cells incubated with as little as 10 µM DCVCS for 24 h exhibited morphological changes, although at least 100 µM DCVCS was required to produce marked changes. Acute cellular necrosis did not occur until 48 h with at least 200 µM DCVCS, indicating that this is a high-dose, late response. The extent of necrosis was similar to that with DCVC. In contrast, apoptosis occurred as early as 1 h with as little as 10 µM DCVCS and the extent of apoptosis was much less than that with DCVC. Mitochondrial function was maintained with DCVCS concentrations up to 100 µM, consistent with hPT cells only being competent to undergo apoptosis at early time points and relatively low concentrations. Marked depletion (>50%) of cellular GSH content was only observed with 500 µM DCVCS. These results, combined with previous studies showing protection from DCVC-induced necrosis and apoptosis by the FMO inhibitor methimazole, suggest that formation of DCVCS plays a significant role in trichloroethylene-induced renal cellular injury in hPT cells.


Received for publication October 25, 2002
Accepted February 21, 2003.

Address correspondence to: Dr. Lawrence H. Lash, Department of Pharmacology, Wayne State University School of Medicine, 540 East Canfield Ave., Detroit, MI 48201. E-mail: l.h.lash{at}wayne.edu




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
R. M. Novick, A. M. Mitzey, M. S. Brownfield, and A. A. Elfarra
Differential Localization of Flavin-Containing Monooxygenase (FMO) Isoforms 1, 3, and 4 in Rat Liver and Kidney and Evidence for Expression of FMO4 in Mouse, Rat, and Human Liver and Kidney Microsomes
J. Pharmacol. Exp. Ther., June 1, 2009; 329(3): 1148 - 1155.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
Z. P. Shaik, E. K. Fifer, and G. Nowak
Akt activation improves oxidative phosphorylation in renal proximal tubular cells following nephrotoxicant injury
Am J Physiol Renal Physiol, February 1, 2008; 294(2): F423 - F432.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. A. Elfarra and R. J. Krause
S-(1,2,2-Trichlorovinyl)-L-cysteine Sulfoxide, a Reactive Metabolite of S-(1,2,2-Trichlorovinyl)-L-cysteine Formed in Rat Liver and Kidney Microsomes, Is a Potent Nephrotoxicant
J. Pharmacol. Exp. Ther., June 1, 2007; 321(3): 1095 - 1101.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
D. Newman, N. Abuladze, K. Scholz, W. Dekant, V. Tsuprun, S. Ryazantsev, G. Bondar, P. Sassani, I. Kurtz, and A. Pushkin
Specificity of Aminoacylase III-Mediated Deacetylation of Mercapturic Acids
Drug Metab. Dispos., January 1, 2007; 35(1): 43 - 50.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
W. A. Chiu, S. Micallef, A. C. Monster, and F. Y. Bois
Toxicokinetics of Inhaled Trichloroethylene and Tetrachloroethylene in Humans at 1 ppm: Empirical Results and Comparisons with Previous Studies
Toxicol. Sci., January 1, 2007; 95(1): 23 - 36.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
E. A. Lock and C. J. Reed
Trichloroethylene: Mechanisms of Renal Toxicity and Renal Cancer and Relevance to Risk Assessment
Toxicol. Sci., June 1, 2006; 91(2): 313 - 331.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
E. D. Kharasch, J. L. Schroeder, T. Bammler, R. Beyer, and S. Srinouanprachanh
Gene Expression Profiling of Nephrotoxicity from the Sevoflurane Degradation Product Fluoromethyl-2,2-difluoro-1-(trifluoromethyl)vinyl Ether ("Compound A") in Rats
Toxicol. Sci., April 1, 2006; 90(2): 419 - 431.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
B. Wegner, P. Baer, S. Gauer, G. Oremek, I. A. Hauser, and H. Geiger
Caspofungin is less nephrotoxic than amphotericin B in vitro and predominantly damages distal renal tubular cells
Nephrol. Dial. Transplant., October 1, 2005; 20(10): 2071 - 2079.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics.